She subsequently underwent a nipple-sparing mastectomy, with pathology indicating a triple-negative invasive ductal carcinoma (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 all negative). The gene discussed is ERBB2; the disease is invasive ductal breast carcinoma.